|
|
Article: Collaboration for Aspirin Resistance Testing Announced by Corgenix Medical Corporation, Creative Clinical Concepts, Inc. and McMaster University.
- Article from:
- PR Newswire
- Article date:
- November 8, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Technology Used to Determine a Patient's Response to Aspirin Therapy Taken to Prevent Heart Attacks
Corgenix Medical Corporation ("Corgenix") (BULLETIN BOARD: CONX) and AspirinWorks, a division of Creative Clinical Concepts, Inc. ("CCC"), both headquartered in Denver, Colorado, today announced that together they have entered into a license agreement with McMaster University ("McMaster"), Hamilton, Ontario, providing Corgenix and CCC exclusive rights to the propriety technology owned by McMaster for the development, manufacturing and marketing of innovative diagnostic tests specific to the pathway by which aspirin acts on platelets. This technology has ...
Related newspaper, magazine, and journal articles:
|
|
Article: MCMASTER UNIVERSITY: McMaster ...
M2 Presswire;
June 11, 1999 ;
499 words
...M2 PRESSWIRE-11 June 1999-MCMASTER UNIVERSITY: McMaster University president re-appointed for a second term ... COMMUNICATIONS LTD RDATE:100699 Hamilton -- McMaster University's Board of Governors has unanimously approved ...
|
|